"The year 2023 marks a decade since the proposal of the Belt and Road Initiative. Throughout this period, Baheal Pharma Group has effectively utilized its prominence within the medical health sector to actively engage with and contribute towards it. Capitalizing on its industry resources, Baheal has been instrumental in revving up growth across participating countries and regions through the provision of high-quality medical health services. As the 10th anniversary of the initiative draws near, Baheal remains deeply committed, taking part in crucial events and making significant contributions to the construction of the Belt and Road with tangible actions.

From October 17th to 18th, the third "Belt and Road" International Cooperation Summit Forum, themed "High-Quality Joint Construction of the Belt and Road: Collaborating towards Common Development and Prosperity", was held in Beijing. Representatives from over 140 countries and more than 30 international organizations attended the forum. Baheal, for its part, was invited to and attended the Entrepreneurs Conference, an opening event for the Forum. Alongside delegates from 80+ countries and regions, they delved into potential strategies to boost global health industry development and upgrades, effectively benefiting countries and their people along the Belt and Road route.

"On the same day, a delegation from the Laos Ministry of Health, led by Minister Bounfeng Phoummalaysith, paid a visit to Baheal. The two parties had a friendly exchange on the advancement of cooperation under the framework of the Belt and Road Initiative. Both sides unanimously agreed to deepen their collaboration in medical technology innovation, drug research and development, and introduction of medical equipment based on previous initiatives concerning health information aid. The aim is to unearth more mutually beneficial opportunities and actively contribute to the Sino-Laotian friendship and the health and wellness of both nations' peoples.

In addition, Baheal signed a Memorandum of Understanding (MoU) with the Ethiopia Investment Commission (EIC). Both parties reached a consensus on Ethiopia's development intentions and potential in high-end medical equipment, pharmaceuticals, and medical technology. They will further explore investment opportunities in these fields in an effort to better spur Ethiopia's health and socio-economic development.

"As an enthusiastic contributor to China's international health collaborations, Baheal has enthusiastically embraced and actively propelled the development of the Belt and Road Initiative. Beginning in 2016, Baheal has been collaborating with hospitals in Laos, pioneering upgrades to their IT infrastructure and successively implementing many medical informatization ventures in healthcare facilities throughout Laos and Cambodia. These endeavors have considerably fortified practical cooperation with Southeast Asian Belt and Road nations and have meaningfully elevated local quality of life. Both local governments as well as community members have accorded high praise to Baheal's significant contributions."

"The Belt and Road Initiative is ushering in transformative prospects on a global scale, with Baheal being privileged to be an integral part of this change. Moving forward, the company will steadfastly echo the Belt and Road Initiative, staying true to its guiding principle of 'refining the healthcare field through technological innovation.' Baheal plans on forging wider, more profound, and elevated partnerships with governments and corporations from countries participating in the Belt and Road Initiative. By facilitating the widespread accessibility of the fruits of Baheal's healthcare advancements and innovations, the company is aiming to breathe new life and vigor into the Belt and Road Initiative, assisting in the perpetual enhancement of global health and overall wellness."